mesalamine has been researched along with Left Ventricular Dysfunction in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Ye, J | 1 |
| Zhu, J | 1 |
| Chen, W | 1 |
| Sun, Y | 1 |
1 other study available for mesalamine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Myocarditis due to mesalamine treatment in a patient with Crohn's disease in China.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; China; Crohn Disease; Echocardiography; Electrocardi | 2012 |